Literature DB >> 20550457

The curious incident of the dog in the nighttime: does the absence of virus replication in Epstein-Barr virus-transformed B cells point to an important feature of JC virus biology?

Sidney A Houff, Joseph Berger.   

Abstract

Entities:  

Mesh:

Year:  2010        PMID: 20550457     DOI: 10.1086/653824

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  7 in total

1.  Orderly Steps in Progression of JC Virus to Virulence in the Brain.

Authors:  Edward M Johnson; Margaret J Wortman; Patric S Lundberg; Dianne C Daniel
Journal:  Brain Disord Ther       Date:  2015-07-13

2.  JC polyomavirus expression and bell-shaped regulation of its SF2/ASF suppressor during the follow-up of multiple sclerosis patients treated with natalizumab.

Authors:  Elena Uleri; Gabriele Ibba; Claudia Piu; Maurizio Caocci; Stefania Leoni; Giannina Arru; Caterina Serra; GianPietro Sechi; Antonina Dolei
Journal:  J Neurovirol       Date:  2016-11-03       Impact factor: 2.643

3.  Opportunistic DNA Recombination With Epstein-Barr Virus at Sites of Control Region Rearrangements Mediating JC Virus Neurovirulence.

Authors:  Margaret J Wortman; Patric S Lundberg; Ayuna V Dagdanova; Pranav Venkataraman; Dianne C Daniel; Edward M Johnson
Journal:  J Infect Dis       Date:  2015-12-21       Impact factor: 5.226

4.  Pre-existing T- and B-cell defects in one progressive multifocal leukoencephalopathy patient.

Authors:  Alessandra Sottini; Ruggero Capra; Cinzia Zanotti; Marco Chiarini; Federico Serana; Doris Ricotta; Luigi Caimi; Luisa Imberti
Journal:  PLoS One       Date:  2012-04-04       Impact factor: 3.240

Review 5.  Immunological Markers for PML Prediction in MS Patients Treated with Natalizumab.

Authors:  Caroline Antoniol; Bruno Stankoff
Journal:  Front Immunol       Date:  2015-01-05       Impact factor: 7.561

6.  Significance of Interviral Recombination as Novel Mechanism for Extending Viral Disease Repertoire.

Authors:  Edward M Johnson; Dianne C Daniel
Journal:  Brain Disord Ther       Date:  2016-06-23

Review 7.  Understanding Progressive Multifocal Leukoencephalopathy Risk in Multiple Sclerosis Patients Treated with Immunomodulatory Therapies: A Bird's Eye View.

Authors:  Elizabeth A Mills; Yang Mao-Draayer
Journal:  Front Immunol       Date:  2018-02-02       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.